Occulogic
Natural health product licensed in Canada
- Licence holder
- RX BALANCE TECHNOLOGY INC.
- NPN or DIN-HM
- 80001026
- Status
- Active licence
- Licence date
- 10 November 2005
- Revision date
- Not provided
- Form
- Caplet
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc | 20 mg | Not calculated |
| Vitamine C | 100 mg | Not calculated |
| Lutéine | 5 mg | Not calculated |
| Ginkgo biloba | 40 mg | Not calculated |
| Cuivre | 1 mg | Not calculated |
Non-medicinal ingredients
Croscarmellose de sodium, Stéarate de magnésium végétal, Hypromellose, Carbonate de calcium, Acide stéarique, Dioxyde de silicium, Poly(éthylène glycol), Purple Carmine, cellulose, Cire de Carnauba, Calcium Silicate
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Caplet | Not specified |
Uses authorised in Canada
To maintain vision health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking platelet aggregation inhibitors such as Acetylsalicylic acid, anticoagulant(s), Fluoroquinolones, Penicillamine and Tetracyclines.
- Effets indésirables connus
Discontinue use if experiencing mild gastrointestinal upset, nausea, vomiting, headache, dizziness, palpitations, constipation or allergic reactions.
- Contre-indications
Do not use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80001026
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.